ICLR - ICON Public Limited Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

ICON Public Limited Company

South County Business Park
Dublin 18
353 1 291 2000

IndustryDiagnostics & Research
Full Time Employees14,400

Key Executives

NameTitlePayExercisedYear Born
Dr. Steven A. CutlerCEO & Director2.62MN/A1960
Mr. Brendan BrennanChief Financial Officer979kN/A1979
Jonathan CurtainVP of Corp. Fin. & Investor RelationsN/AN/AN/A
Mr. Thomas O'LearyChief Information OfficerN/AN/AN/A
Mr. Diarmaid CunninghamChief Admin. Officer, Gen. Counsel, Exec. VP & Company Sec.N/AN/A1975
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


ICON Public Limited Company, a clinical research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. It specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. The company's clinical development services include product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, site feasibility, patient recruitment and retention, digital patient and site, project management, clinical operations/monitoring, patient centric monitoring, data management, and adaptive and virtual trial services. Its clinical development services also comprise medical imaging, biostatistics, medical affairs, pharmacovigilance, strategic regulatory, electronic endpoint adjudication, medical writing and publishing, interactive response technologies, functional, strategic resourcing central laboratory, bioanalytical laboratory, biomarket development, strategy and analytics, late phase research, patient centered science, and medical device and diagnostics research services, as well as access, commercialization, and communication services, and research trials for us government agencies. The company was founded in 1990 and is headquartered in Dublin, Ireland.

Corporate Governance

ICON Public Limited Company’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.